What do we Know about Secondary Hyperparathyroidism

• Authors: Wojciech Cichoń , Stanisław Cichoń
• Languages of publication: EN

Abstracts

EN

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2008
• Volume: 80
• Issue: 9
• Pages: 495-505

Dates

published

1 - 9 - 2008

online

25 - 9 - 2008

Contributors

author

Wojciech Cichoń

• Departament of Endocrine Surgery, 3 Chair of General Surgery, Jagiellonian University College of Medicine, Cracow

author

Stanisław Cichoń

• Departament of Endocrine Surgery, 3 Chair of General Surgery, Jagiellonian University College of Medicine, Cracow

References

• Eknoyan G: A history of the parathyroid glands. Am J Kidney Dis 1995; 26: 801-07.[PubMed][Crossref]
• Karwacki JH, Skalski A, Krajewska M: Evaluation of total parathyroidectomy with simultaneous autotransplantation for the treatment of secondary hyperparathyroidism - our own experience. Adv in Clin & Exper Med 2003; 12: 321-27.
• Thomas Jr CG: Presidential address: The glands of Owen - A perspective on the history of hyperparathyroidism. Surgery 1990; 108: 939-50.
• Chou F-F, Lee C-H, Chen J-B.: General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism. Arch Surg 1999; 134: 1108-11.[Crossref][PubMed]
• Chaffanjon PCJ, Brichon P-Y, Sarrazin R: Bilateral Oblique Approach to Parathyroid Glands. Ann Surgery 2000; 231: 25.[Crossref]
• Jovanovic DB, Pejanovic S, Vukovic L et al.: Ten years' experience in subtotal parathyroidectomy of hemodialysis patients. Renal Failure 2005; 27: 19-24.
• Mourad M, Ngongang C, Saab N et al.: Video-assisted neck exploration for primary and secondary hyperparathyroidism: Initial experience. Surg Endosc 2001; 15: 1112-15.[Crossref]
• Dadan J, Dzięcioł J, Ładny J i wsp.: Chirurgiczne leczenie pierwotnej i wtórnej nadczynności przytarczyc. Przegl Lek 2002; 59: 84-87.
• Hibi Y, Tominaga Y, Uchida K et al.: Casus with fewer than four parathyroid glands In patients with renal hyperparathyroidism At initial parathyroidectomy. World J Surg 2002; 26: 314-17.
• Hines OJ, Gordon HE: Secondary hyperparathyroidism In a patent with eight parathyroid glans. J Clin Endoc and Metab 1998; 83: 2384-86.
• Kuwahara M, Kagawa J, Takemura M et al.: A study of abnormal parathyroid glands in secondary hyperparathyroidism. Nishin J Urol 2004; 66: 177-84.
• Numano M, Tominaga Y, Uchida K et al.: Surgical significance of supranumerary parathyroid glans in renal hyperparathyroidism. World J Surg 1998; 22: 1098-1103.[Crossref]
• Decker PA, Cohen EP, Doffek KM et al.: Subtotal parathyroidectomy in renal failure: still need after these years. World J Surg 2001; 25: 708-12.[PubMed][Crossref]
• Garcia-Pallares M, Bernaldez R, Sanchez MC et al.: Surgery for secondary hyperparathyroidism in patients undergoing dialysis. Otolaryng - Head & Neck Surg 2000; 122: 908-10.
• Gasparri G, Camandona M, Abbona GC et al.: Secondary and Tertiary Hyperparathyroidism: Causes of Recurrent Disease After 446 Parathyroidectomies. Ann Surgery 2001; 233: 65-69.[Crossref]
• Ockert S, Willeke F, Richter A et al.: Total parathyroidectomy without autotransplantation as a standard procedure in the treatment of secondary hyperparathyroidism. Lang Arch Surg 2002; 387: 204-09.[PubMed]
• Koch Noguiera PC, Rey N, Said MH et al.: Evolution of hyperparathyroidism after ranal transplantation in children - effect of pre-emptive transplantation and duration of dialysis. Nephr Dialysis Transpl 1997; 12: 984-87.
• Kokot F, Ficek R: Parathormon, nowe aspekty patofizjologiczne. Terapia 2002
• Locatelli F, Cannata-Andia JB, Drueke TB et al.: Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephr Dialysis Transpl 2002; 17: 723-31.[PubMed]
• Goodman WG: Medical management of secondary hyperparathyroidism in chronic renal failure. Nephr Dialysis Transpl 2003; 18 suppl. 3: iii2-iii8.
• Czupryniak A, Nowicki M: Współczesne sposoby zapobiegania i leczenia wtórnej nadczynności przytarczyc u chorych z przewlekłą niewydolnością nerek. Endokr Pol 2003; 54: 195-202.
• Chudek J, Piecha G, Marcinkowski W i wsp.: Resorpcja masywnych zwapnień tkanek miękkich po subtotalnej paratyreoidektomii u chorego z przewlekłą niewydolności nerek leczonego powtarzanymi hemodializami. Nefr i Dializ Pol 2002; 6: 193-96.
• Janicka L, Karski J, Janicki K i wsp.: Wpływ paratyreoidektomii na wskaźniki biochemiczne i kliniczne cięzkiej wtórnej nadczynności przytarczyc u pacjentów przewlekle hemodializowanych. Nephr Dialysis Transpl 2001; 5: 205-08.
• Johnson JC, Williams CR, Ebrom JS: Bilateral dense breast calcifications in secondary hyperparathyroidism. J Women's Imag 2004; 6: 45-48.
• Tokumoto M, Tsuruya K, Fukuda K et al.: Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27. Nephr Dialysis Transpl 2003; 18 suppl. 3: iii9-iii12.
• Akerstrom G, Juhlin C: Surgical treatment of secondary hyperparathyroidism. Acta Chir Austriaca 1996; 28 (suppl. 124): 26-28.
• Chudek J, Karkoszka H, Więcek A et al.: Secondary hyperparathyroidism resistant to active witamin D is not unique to renal failure- observations In a patent with distal tubular acidosis and pancreatogenic malabsorption. Nephr Dialysis Transpl 1998; 13: 776-78.
• Ritz E, Matthias S, Reichel H et al.: Therapeutic strategies in patients with renal insufficiency and secondary hyperparathyreoidism. Nieren-und Hochdruckkrankheiten 1994; 23 (suppl. 2): S71-S77.
• Horl WH: Secondary hyperparathyroidism: Present and future therapeutic implications. Nephr Dialysis Transpl 2002; 17: 732-33.[PubMed]
• Jeren-Strujic B, Rozman B, Lambasa S et al.: Secondary hyperparathyroidism and brown tumor in dialyzed patients. Renal Failure 2001; 23: 279-86.[Crossref]
• Waller S, Reynolds A, Ridout D et al.: Parathyroid hormone and its fragments in children with chronic renal failure. Ped Nephr 2003; 18: 1242-48.[Crossref]
• Barzel US, Hruska KA: Renal Osteodystrophy. New Engl J Med 1995; 333: 1428.
• Girotto JA, Harmon JW, Ratner LE et al.: Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 2001; 130: 645-51.[PubMed][Crossref]
• Zupan-Kajcovski B, Mekkes JR: Successful treatment of calciphylaxis with parathyroidectomy. Nederlands Tijdschrift voor Derm & Vener 2004; 14: 192-94.
• Nieto J, Ruiz-Cuevas P, Escuder A et al.: Tertiary hyperparathyroidism after renal transplantation. Ped Nephr 1997; 11: 65-68.[Crossref]
• Hamada C, Fukui M, Sakamoto T et al.: Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis. Nephrology 2003; 8: 116-20.[Crossref]
• Kovatcheva R, Radeva M, Kirilov G et al.: Diagnostic value of high-resolution color Doppler ultrasonography and 99mTc-MIBI scintigraphy in primary and secondary hyperparathyroidism. Rentgen and Radiol 2004; 43: 188-94.
• Takai K, Matsumura M, Uchiyama K et al.: Usefulness of diagnostic and treatment imaging in cases of chronic renal failure. Nishinihon J Urol 2004; 66: 361-65.
• Tanaka Y, Tominaga Y, Funahashi H et al.: Preoperative localization studies in secondary hyperplasia. Acta Chirur Austr 1996; 28 (suppl. 124): 14-16.
• Tomic-Brzac H, Pavlovic D: Ultrasound methods in diagnosis of renal osteodystrophy. Acta Med Croatica 2004; 58: 43-49.
• Barczyński M, Cichoń S, Konturek A: Przydatność śródoperacyjnego oznaczania parathormonu we wtórnej nerkopochodnej nadczynności przytarczyc - obserwacje wstępne. Pol Przegl Chir 2003; 75: 966-82.
• Fujimoto N, Itoh K, Kishikawa H et al.: Preoperative localization of enlarged parathyroid glands by 99mT- mibi scintigraphy. Japan J Urol 1997; 88: 795-800.
• Katagiri M, Ohtawa T, Otsuka N et al.: Detection and localization of enlarged parathyroid glands in patients with hyperparathyroidism using 99mTc-methoxyisobutylisonitrile (MIBI): A study of subtraction scintigraphy with 99mTc-pertechnetate. Kakuigaku 1995; 32: 465-72.
• Kosowicz J, Bolko P, Swiderski A: Wyniki scyntygrafii układu kostnego, densytometrii i badań radiologicznych u pacjentów z wtórną nadczynnością przytarczyc w przebiegu przewlekłej niewydolności nerek. Pol Arch Med Wew 2003; 109:, 125-35.
• Olaizola I, Zingraff J, Heuguerot C et al.: 99mTc sestamibi parathyroid scyntigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephr Dialysis Transpl 2000; 15: 1201-06.
• Hindie E, De Labriolle-Vaylet C, Melliere D et al.: Parathyroid gland radionuclide scanning - Methods and indications. Joint, Bone, Spine: Revue du Rhum 2002; 69: 28-36.
• Jeanguillaume C, Urena P, Hindie E et al.: Secondary hyperparathyroidism: Detection with I-123-Tc-99m-sestamibi subtraction scintigraphy versus US. Radiology 1998; 207: 207-14.
• Neumann DR, Esselstyn CB, Madera A et al.: Parathyroid detection in secondary parathyroidism with 123I)99mTc-sestaMIBI subtraction single photon emission computed tomography. J Clin Endocr and Metab 1998; 83: 3867.
• Spanu A, Migaleddu V, Manca A et al.: The usefulness of single photon emission computerized tomography with pinhole collimator (PSPECT) in preoperative localization of hyperfunctioning parathyroid glands in patients with secondary hyperparathyroidism. Radiol Med 2003; 106: 399-412.
• Suehiro M, Fukuchi M: Localization of hyperfunctioning parathyroid glands by means of thallium-201 and iodine-131 subtraction scintigraphy in patients with primary and secondary hyperparathyroidism. Ann Nucl Med 1992; 6: 185-90.[PubMed][Crossref]
• Vicente Torregrosa J, Palomar MR, Pons F et al.: Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephr Dialysis Transpl 1998; 13 suppl. 3: 37-40.
• Katoh N, Nakayama M, Shigematsu T et al.: Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 2000; 35: 465-68.[PubMed][Crossref]
• Ishibashi M, Nishida H, Hiromatsu Y et al.: Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998; 39: 320-24.
• Janko O, Hubmann R, Zazgornik J et al.: Recurrent hyperparathyroidism after total parathyroidectomy due to multiple ectopic parathyroid glands in a patient with long-term haemodialysis. Wiener Medizinische Wochenschrift 2001; 151: 288-90.
• Wada A, Sugihara M, Sugimura K et al.: Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism. Rad Med 1999; 17: 275-82.
• Chertow GM: Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephr 2003; 14 (suppl. 4): S310-S314.[Crossref]
• Drueke TB: Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis. Nephr Dialysis Transpl 2002; 17 suppl. 11: 20-22.[PubMed]
• Hruska KA, Teitelbaum SL: Renal Osteodystrophy. The New Eng J Med 1995; 333: 166-74.
• Ogata H, Ritz E, Odoni G et al.: Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephr 2003; 14: 959-67.[Crossref]
• Tominaga Y, Sato K, Numano M et al.: Surgical treatment of renal hyperparathyroidism. Asian J Surgery 1994; 17: 121-26.
• Akizawa T, Suzuki M, Akiba T et al.: Long-term effect of 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. Nephr Dialysis Transpl 2002; 17 (suppl. 10): 28-36.
• Reginster JY, Zegels B, Lejeune E et al.: Influence of daily regimen calcium and vitamin D supplementation on parathyroid hormone secretion Calcific Tissue Inter 2002; 70: 78-82.
• Upton RA, Knutson JC, Bishop CW et al.: Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone. Nephr Dialysis Transpl 2003; 18: 750-58.
• Fukugawa M, Kitaoka M, Tominaga Y et al.: Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephr Dialysis Transpl 2003; 18 suppl. 3: iii31-iii33.
• Giangrande A, Castiglioni A, Solbiati L et al.: Chemical parathyroidectomy for recurrence of secondary hyperparathyroidism. Am J Kidney Dis 1994; 24: 421-26.
• Koiwa F, Hasegawa T, Kojima I et al.: Time course of change in calcium x phosphorus product after percutaneous ethanol injection therapy. Nephr Dialysis Transpl 2003; 18 suppl. 3: iii53-iii57.
• Takeda S-I, Michigishi T, Takazakura E: Successful ultrasonically guided percutaneous ethanol injection for secondary hyperparathyroidism. Nephron 1992; 62: 100-03.[PubMed][Crossref]
• Tanaka R, Kakuta T, Fujisaki T et al.: Longterm (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephr Dialysis Transpl 2003; 18 suppl. 3: iii58-iii61.
• Kitaoka M, Onoda N, Kitamura H et al.: Percutaneous calcitriol injection therapy (PCIT) for secondary hyperparathyroidism: Multicentre trial. Nephr Dialysis Transpl 2003; 18 (suppl. 3): iii38-iii41.
• Nakanishi S, Yano S, Nomura R et al.: Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism. Nephr Dialysis Transpl 2003; 18: (suppl. 3), iii47-iii49.
• Yamamoto H, Katoh N, Takeyama H et al.: Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients. Nephr Dialysis Transpl 2003; 18 (suppl. 3): iii50-iii52.
• Salusky IB, Goodman WG: Parathyroid gland function in secondary hyperparathyroidism. Ped Nephrol 1996; 10: 359-63.
• Tominaga Y, Kohara S, Namii Y et al.: Clona analysis of nodular parathyroid hyperplasia in renal parathyroidism. World J Surg 1996; 20: 744-52.[Crossref]
• Tominaga Y, Tanaka Y, Sato K et al.: Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Seminars in Surg Oncol 1997; 13: 78-86.
• Ohe MN, Santos RO, Kunii IS et al.: Usefulness of rapid immunometric assay for intraoperative parathyroid hormone measurements. Brazilian J Med and Biol Res 2003; 36: 715-21.
• Pavlovic D, Brzac HT: Prevention and treatment of secondary hyperparathyroidism: Still a challenge for the nephrologist? Nephr Dialysis Transpl 2003; 18 (suppl. 5): v45-v46.
• Sugimura T, Yamagami S: The effect of conservative and surgical management for secondary hyperparathyroidism and their problems. Acta Urol Jap 1991; 37: 1203-08.
• Tominaga Y, Sato K, Numano M et al.: Indications for parathyroidectomy in renal hyperparathyroidism. Acta Chir Austriaca 1996; 28 (suppl. 124): 10-13.
• Kinnaert P, Tielemans C, Dhaene M et al.: Evaluation of surgical treatment of renal hyperparathyroidism by measuring intact parathormone blood levels on fist postoperative day. World J Surg 1998; 22: 695-99.[Crossref]
• Llach F: Parathyroidectomy in chronic renal failure: Indications, surgical approach and the use of calcitriol. Kidney Int 1990; 38: suppl. 29.
• Pasieka JL: Surgical approach to secondary hyperparathyroidism. Probl in General Surg 2003; 20: 61-67.
• Halevy A, Stepansky A, Halpern Z et al.: Quick parathormone assay in the surgical management of hyperparathyroidism. Israel Med Assoc J 2003; 5: 775-77.
• Yamashita H, Gao P, Cantor T et al.: Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery 2004; 135: 149-56.[PubMed][Crossref]
• Fabretti F, Calabrese V, Fornasari V et al.: Subtotal parathyroidectomy for secondary hyperparathyroidism in chronic renal failure. J Laryn & Otology 1991; 105: 562-67.
• Goicoechea Diezhandino M, Polo JR, Gomez-Campdera F et al.: Total parathyroidectomy with autograft in patients on dialysis: PTH gradient as assessment of parathyroid function. Nephrologia 1995; 15: 62-67.
• Korzets Z, Magen H, Kraus L et al.: Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism: Should it be abandoned? Nephr Dialysis Transpl 1987; 2: 341-46.
• Schlosser K, Sitter H, Rothmund M et al.: Assesing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 2004; 28: 583-88.
• Niederle B: The technique of parathyroid cryopreservation and the results of delayed autotransplantation - A review. Acta Chir Austriaca 1996; 28: suppl. 124, 68-71.
• Chou F-F, Chen J-B, Lee C-H et al.: Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Arch Surg 2001; 136: 1064-68.[PubMed][Crossref]
• Chou F-F, Ho J-C, Huang S-C et al.: A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am College Surg 2000; 190: 65-70.
• Conzo G, Celsi S, Buffardi R et al.: Total parathyroidectomy with or without autoimplantion in the therapy of secondary hyperparathyroidism. Minerva Chir 2002; 57: 309-15.[PubMed]
• Gomez-Fernandez P, Sanchez Agudo L, Miguel JL et al.: Effect of parathyroidectomy on respiratory muscle strength in uremic myopathy. Am J Nephrol 1987; 7: 466-69.
• Chou F-F, Lee C-H, Shu K et al.: Improvement of sexual function in male patients after parathyroidectomy for secondary hyperparathyroidism. J Am College Surg 2001; 193: 486-92.
• Cattan P, Halimi B, Aidan K et al.: Reoperation for secondary uremic hyperparathyroidism: Are technical difficulties influenced by initial surgical procedure? Surgery 2000; 127: 562-65.[PubMed][Crossref]
• Liew V, Gough IR, Nolan G et al.: Re-operation for hyperparathyroidism. Austr and New Zeland J Surg 2004; 74: 732-40.
• Tominaga Y, Katayama A, Sato T et al.: Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephr Dialysis Transpl 2003; 18 (suppl. 3): iii65-iii70.
• Kessler M, Avila JM, Renoult E: Mathieu P. Reoperation for secondary hyperparathyroidism in chronic renal failure. Nephr Dialysis Transpl 1991; 6: 176-19.

Identifiers

DOI

10.2478/v10035-008-0071-9